Rx-to-OTC Switch Of Menopause Treatment Approved In UK
Executive Summary
Women in the UK will soon have OTC access to a low-dose Hormone Replacement Therapy drug following the reclassification of Novo Nordisk's Gina.
You may also be interested in...
P&G Clearblue Line Extension, Kenvue Survey Of 4,500 Women Target Menopause Market
P&G announces Clearblue Menopause Stage Indicator launch noting more than two in three women feel unprepared for menopause and less than half say they have enough information to manage it. Kenvue survey results show prior to age 50, proportion of women experiencing symptoms attributable to menopause is significantly greater than the proportion that self-reports.
PAGB Survey Shows Brits Losing Confidence In Self-Care, Time For UK Government To Act
UK consumers “may be falling back into pre-pandemic behaviours and there is a time-limited opportunity to embed the changes people had embraced during the pandemic,” argues PAGB CEO Michelle Riddalls as the association publishes its latest self-care survey.
Novo Nordisk Launches OTC HRT Treatment In UK
The first hormone replacement therapy drug sold without a prescription in the UK is now available in Boots pharmacies across the country.